17 beta-acetamide-4-azasteroids as androgen receptor modulators

Details for Australian Patent Application No. 2005232619 (hide)

International Classifications

Event Publications

9 November 2006 PCT application entered the National Phase

PCT publication WO2005/099707 Priority application(s): WO2005/099707

24 July 2008 Application Accepted

Published as AU-B-2005232619

20 November 2008 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.